Michael Jeltsch

Associate Professor in Pharmaceutical Protein Drug Research

University of Helsinki

Finland

Research Interests

Explore related searches

Professors in Finland Professors in Tissue Engineering Tissue Engineering professors in Finland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Michael Jeltsch is an Associate Professor in Pharmaceutical Protein Drug Research at the University of Helsinki. His research focuses on various aspects of drug treatment for diseases such as Parkinson's, immunomodulatory effects of nanocarriers, and the relationship between vascular systems in different organisms. He has contributed to the understanding of allosteric activators and the molecular mechanisms underlying lymphatic growth and regeneration.

Articles (14)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (16)

Harri Nurmi

University of Helsinki

FINLAND

Michael Jeltsch

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Targeting Bacterial and Human Levodopa Decarboxylases for Improved Drug Treatment of Parkinson's Disease: Discovery and Characterization of New Inhibitors

Fetal-like reversion in the regenerating intestine is regulated by mesenchymal asporin

Study of the Synergistic Immunomodulatory and Antifibrotic Effects of Dual-Loaded Budesonide and Serpine1 siRNA Lipid–Polymer Nanoparticles Targeting Macrophage Dysregulation in Tendinopathy

Gliflozins, sucrose and flavonoids are allosteric activators of lecithin-cholesterol acyltransferase

The relationship between the secondary vascular system and the lymphatic vascular system in fish

Expansion and collapse of VEGF diversity in major clades of the animal kingdom

Bioactive VEGF-C from E. coli

Lymphatic-to-blood vessel transdifferentiation in zebrafish

KLK3 in the Regulation of Angiogenesis—Tumorigenic or Not?

Outside in and brakes off for lymphatic growth

Proteolytic Cleavages in the VEGF Family: Generating Diversity among Angiogenic VEGFs, Essential for the Activation of Lymphangiogenic VEGFs

VEGF-C protects the integrity of the bone marrow perivascular niche in mice

Lymphatics and the Eye

Investigation on the role of biallelic variants in VEGF-C found in a patient affected by Milroy-like lymphedema.

Collaborators (16)

Harri Nurmi

Akseli Niemelä

Zuzana Varaliová

Hélder A. Santos

Jayendra Z. Patel

Peter Steinberger

Saara Ollila

Hjalte List Larsen

Kari Alitalo

Sandra López Cerdá

Hannu Koistinen

Emma Viitala

Khushbu Rauniyar

DANIELA NEGRINI

Jouni Tapio Hirvonen

Goncalo Barreto

Make your next move.